United States News Todas as matérias

Incyte (NASDAQ:INCY) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of Opzelura (ruxolitinib) cream for the treatment of moderate atopic dermatitis in adult patients for whom topical corticosteroids and topical calcineurin inhibitors are inadequate or inappropriate.

Lilly (NYSE:LLY) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending marketing authorization for Jaypirca (pirtobrutinib) in adults with chronic lymphocytic leukemia (CLL).

Axsome Therapeutics (NASDAQ:AXSM) announced that the first patient has been dosed in the FOCUS-3 Phase 3 trial of solriamfetol for the treatment of attention deficit hyperactivity disorder (ADHD) in adolescents.

Fortrea (NASDAQ:FTRE) appointed Jason Knoblauch as Chief Financial Officer, effective July 6, 2026.

Beyond Air (NASDAQ:XAIR) reported fiscal 2026 revenue of $7.7 million, an increase of 107% year over year.

Daiichi Sankyo and AstraZeneca (NYSE:AZN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending marketing authorization for Datroway (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple-negative breast cancer who are not candidates for PD-1/PD-L1 inhibitor therapy.

Acadia Pharmaceuticals (NASDAQ:ACAD) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older.

Apogee Enterprises (NASDAQ:APOG) reported net sales of $342.7 million for the first quarter of fiscal 2027 ended May 30, 2026, a decrease of 1.1% from the prior-year period.

SpaceX (NASDAQ:SPCX) is set to join FTSE Russell U.S. indexes after the close of trading on Friday as part of the semi-annual reconstitution.

BHP (NYSE:BHP) announced updates to its executive leadership team as incoming CEO Brandon Craig prepares to assume the role on July 1, 2026.

AerCap (NYSE:AER) delivered the first of three new Airbus A321neo aircraft to Azerbaijan Airlines, marking the aircraft type’s entry into the carrier’s fleet.

Italy’s antitrust authority said it has opened an investigation into Microsoft (NASDAQ:MSFT) over alleged unfair commercial practices linked to price changes in Microsoft 365 subscriptions.

Crude oil prices fell on track for a weekly loss as shipping activity in the Strait of Hormuz showed signs of recovery and tanker traffic increased.

Autoliv (NYSE:ALV) said Kevin Fox will resign as President, Autoliv Americas for personal reasons, with the leadership change taking effect after August 31, 2026.

Bumble (NASDAQ:BMBL) is exploring a potential sale of the company, according to people familiar with the matter.

Apple (NASDAQ) raised prices on several MacBook and iPad models, including lifting the entry-level MacBook Neo from $599 to $699.

Micron Technology (NASDAQ:MU) briefly moved ahead of Meta Platforms (NASDAQ:META) by market value after its AI-driven memory chip forecast lifted the stock more than 18%.

Kroger (NYSE:KR) announced that its Board of Directors approved an 11% increase in the annual dividend from $1.40 to $1.56 per share.

HUTCHMED (NASDAQ:HCM) reported pivotal Phase II data for fanregratinib in pretreated advanced intrahepatic cholangiocarcinoma, with an IRC-assessed objective response rate of 42.5%.

MIRA Pharmaceuticals (NASDAQ:MIRA) reported new preclinical data for Mira-55, its cannabinoid analog candidate for the treatment of chronic inflammatory pain.

GE Aerospace (NYSE:GE) declared a quarterly dividend of $0.47 per share on its outstanding common stock.

Nano-X Imaging (NASDAQ:NNOX) reported Q1 2026 revenue of $4.3 million, up from $2.8 million a year earlier, while net loss reached $14.3 million.

Sunshine Biopharma (NASDAQ:SBFM) received Canadian regulatory approval for its 1mg generic Anastrozole tablets, the equivalent of Arimidex.

Agilent Technologies (NYSE:A) completed its previously announced $950 million acquisition of Biocare Medical, adding the clinical pathology company to its Life Sciences and Diagnostics Markets Group.